Intratumoral CD8+ Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer
2014 · PLoS ONE · 67 citations
https://doi.org/10.1371/journal.pone.0095475
X
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
177
Papers
6.0K
Citations
37
h-index
90
i10-index
Xia Wu is an academic researcher from Guangdong Provincial Occupational Disease Prevention Hospital. The author has contributed to research in topics: RNA modifications and cancer & Cancer Immunotherapy and Biomarkers & Advanced biosensing and bioanalysis techniques. The author has an h-index of 37, co-authored 151 publications.
ORCID: 0000-0002-8151-8076Papers by this author
worksThe role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing
2021 · Journal of Experimental & Clinical Cancer Research · 25 citations
https://doi.org/10.1186/s13046-021-02139-7
CRISPR applications in cancer diagnosis and treatment
2023 · Cellular & Molecular Biology Letters · 22 citations
https://doi.org/10.1186/s11658-023-00483-4
Superoxide dismutase as a protective factor for microalbuminuria in hypertensive patients
2022 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-022-24804-3
Clinical and molecular characteristics of methicillin-resistant Staphylococcus aureus in bone and joint infection among children
2023 · Annals of Clinical Microbiology and Antimicrobials · 6 citations
https://doi.org/10.1186/s12941-023-00654-3
Static training improves insulin resistance in skeletal muscle of type 2 diabetic mice via the IGF-2/IGF-1R pathway
2025 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-025-94360-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat